Strengthen the Core℠
Aesthetic Marketing and Practice Management Consulting℠
8
Jan

Perfect Lips: Natural Shape

Aspen, Colo. – At the summer edition of The Cosmetic Bootcamp (CBC), attendees learned the importance of preserving the infinite variance that occurs in natural lip shapes. Lips remain one of the most commonly treated areas in aesthetic medicine. However, said Beverly Hills-based dermatologist Ava Shamban, M.D., results are often suboptimal. “It’s important to pay...
Read More
4
Jan

The Perfect Lip

Aspen, Colo. – To rejuvenate and balance lips of all shapes, sizes and ages, one must first appreciate the natural variation among normal lips, said an expert at the summer Cosmetic Bootcamp. “Everybody’s lips are unique, and every patient needs a unique approach to giving them the perfect lip for their face,” said Beverly Hills-based...
Read More
11
Dec

Longer-Lasting Neuromodulator?

Aspen, Colo. — A new neuromodulator nearing the end of FDA Phase 3 development may last longer than existing options, attendees at the summer Cosmetic Bootcamp (CBC) learned. DaxibotulinumtoxinA includes a positively charged peptide that binds with the negatively charged portion of its unique type A neuromodulator molecule. According to developer Revance, this combination may...
Read More
29
Nov

Avoiding Neuromodulator Complications

Aspen, Colo. — In preventing neuromodulator-related complications, said an expert at the summer Cosmetic Bootcamp (CBC), timing is critical. Neuromodulator complications can include undesired diffusion, especially after treatment with devices that create edema, most commonly after ablative and nonablative laser resurfacing, said Vic Narurkar, M.D. That’s why he only does same-day neuromodulator injections after procedures...
Read More
27
Nov

Neuromodulators on the US Horizon

Aspen, Colo. — At the summer edition of The Cosmetic Bootcamp (CBC), attendees learned about new neuromodulators that are likely to join Botox, Dysport and Xeomin on the US market. PrabobotulinumtoxinA (Nabota, Daewoong/Evolus) earned South Korean regulatory approval in 2013. This neuromodulator differs from onabotulinumtoxinA structurally, said Kenneth Beer, M.D., and in the design of...
Read More
1 2 3 20